
LYNK Solutec
Pioneering medical device coating technology to tackle infection, inflammation, and thrombosis, enhancing patient and provider outcomes.
Date | Investors | Amount | Round |
---|---|---|---|
investor | €0.0 | round | |
N/A | €0.0 | round | |
investor | €0.0 | round | |
* | KRW1.5b | Seed | |
Total Funding | 000k |
Related Content
Lynk Solutec specializes in advanced medical device coating technology aimed at addressing critical challenges in the healthcare sector. The company focuses on developing coatings that significantly reduce infection, inflammation, and thrombosis, thereby improving the safety and efficacy of medical devices. Lynk Solutec collaborates closely with medical experts and engages in continuous research and development to extend the application areas of its technology. The business model revolves around creating value for both patients and healthcare providers by offering solutions that enhance medical device performance. Lynk Solutec operates in the medical field, serving healthcare institutions and medical device manufacturers. Revenue is generated through the commercialization of its proprietary coating technology, which can be applied to various materials such as glass, polymer, and plastic, and is suitable for complex structures. The company is committed to sustainability and societal betterment, aligning its management philosophy with these goals. Keywords: medical devices, coating technology, infection prevention, inflammation reduction, thrombosis inhibition, healthcare, research, development, commercialization, sustainability.